Heterogeneous Increase in CD34-positive Alveolar Capillaries in Idiopathic Pulmonary Fibrosis
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
To elucidate the apparent contradictions in vascular remodeling in the lungs of patients with idiopathic pulmonary fibrosis, we evaluated alveolar vascularity in relation to the various degrees of fibrosis in surgically biopsied lungs of usual interstitial pneumonia. Alveolar capillary endothelial cells were intensely immunoreactive with CD34 but not with von Willebrand factor. Vascular density, that is, the relative ratio of capillary area to total area of alveolar walls, was significantly higher at low grades of fibrosis than in control lungs, whereas vascular density gradually decreased as the degree of fibrosis increased and was lower than that of control lungs in the most extensively fibrotic lesions. No vessels were observed inside fibroblastic foci. The potent angiogenic factors vascular endothelial growth factor and interleukin-8 were abundantly produced by capillary endothelial cells and alveolar epithelial cells in highly vascularized alveolar walls. In contrast, venules with CD34-negative but von Willebrand factor-positive endothelial cells localized in the center of the fibrotic lesions were slightly increased and identified as postcapillary venules by three-dimensional reconstructed images. These results indicate the presence of heterogeneous vascular remodeling in usual interstitial pneumonia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725
Gerdes, J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U., & Stein, H. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.4.1710 · Cited by 4,173
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Simple method of estimating severity of pulmonary fibrosis on a numerical scale.
Ashcroft, T., Simpson, J. M., & Timbrell, V (1988) · Journal of Clinical Pathology · doi:10.1136/jcp.41.4.467 · Cited by 1,680
Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
Kasahara, Y., Tuder, R. M., Taraseviciene-Stewart, L., Le Cras, T. D., Abman, S., Hirth, P. K., Waltenberger, J., & Voelkel, N. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10259 · Cited by 1,112
The vascular endothelial growth factor family of polypeptides
Ferrara, N., Houck, K. A., Jakeman, L. B., Winer, J., & Leung, D. W. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240470305 · Cited by 641
The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis
Keane, M. P., Arenberg, D. A., Lynch, J. P., Whyte, R. I., Iannettoni, M. D., Burdick, M. D., Wilke, C. A., Morris, S. B., Glass, M. C., DiGiovine, B., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1437 · Cited by 382
Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis
Kuwano, K., Hagimoto, N., Kawasaki, M., Yatomi, T., Nakamura, N., Nagata, S., Suda, T., Kunitake, R., Maeyama, T., Miyazaki, H., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5628 · Cited by 345
Precapillary Systemic-pulmonary Anastomoses
Turner-Warwick, M. (1963) · Thorax · doi:10.1136/thx.18.3.225 · Cited by 240
Interstitial Vascularity in Fibrosing Alveolitis
Renzoni, E. A., Walsh, D. A., Salmon, M., Wells, A. U., Sestini, P., Nicholson, A. G., Veeraraghavan, S., Bishop, A. E., Romanska, H. M., Pantelidis, P., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200202-135oc · Cited by 197
Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells
Boussat, S., Eddahibi, S., Coste, A., Fataccioli, V., Gouge, M., HOUSSET, B., Adnot, S., & Maître, B. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.2.l371 · Cited by 147
Ebina, M., Yaegashi, H., Takahashi, T., Motomiya, M., & Tanemura, M. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.5_pt_1.1322 · Cited by 89
Self-citationThe ultrastructure of human fibrosing alveolitis
Coalson, J. J. (1982) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00429611 · Cited by 81
Yamamoto, M., Shimokata, K., & Nagura, H. (1988) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00750582 · Cited by 62
Pacheco, K. A., McCammon, C., Liu, A. H., Thorne, P. S., O'Neill, M. E., Martyny, J., Newman, L. S., Hamman, R. F., & Rose, C. S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2112062 · Cited by 61
DIFFUSE INTERSTITIAL FIBROSIS OF LUNGS
Golden, A. (1953) · A M A Archives of Internal Medicine · doi:10.1001/archinte.1953.00240230006002 · Cited by 57
Maeda, S., Suzuki, S., SUZUKI, T. A., Endo, M., Moriya, T., Chida, M., Kondo, T., & Sasano, H. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780423 · Cited by 57
Self-citationLappi‐Blanco, E., Kaarteenaho–Wiik, R., Soini, Y., Risteli, J., & Pääkkö, P. K. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90036-9 · Cited by 49
Vascularity in human adrenal cortex.
Sasano, H., Ohashi, Y., Suzuki, T., & Nagura, H. (1998) · PubMed · Cited by 45
Self-citation
Cited by
King, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194
Adams, T. S., Schupp, J. C., Poli, S., Ayaub, E. A., Neumark, N., Ahangari, F., Chu, S. G., Raby, B. A., DeIuliis, G., Januszyk, M., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba1983 · Cited by 1,420
“With few exceptions, assessments of vascular remodeling in IPF have primarily focused on pulmonary capillary displacement by nonvascularized patches of fibroblastic lesions with inconclusive observation about potential changes in angiogenesis (33, 34).”
BackgroundMode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
Wollin, L., Wex, E., Pautsch, A., Schnapp, G., Hostettler, K. E., Stowasser, S., & Kolb, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00174914 · Cited by 1,005
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Moss, B. J., Ryter, S. W., & Rosas, I. O. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-030240 · Cited by 821
Review: Evidence That Systemic Sclerosis Is a Vascular Disease
Matucci‐Cerinic, M., Kahaleh, B., & Wigley, F. M. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37988 · Cited by 452
Metadata
- Authors
- Ebina, M., Shimizukawa, M., Shibata, N., Kimura, Y., Suzuki, T., Endo, M., Sasano, H., Kondo, T., & Nukiwa, T.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-06-01
- Volume
- 169
- Issue
- 11
- Pages
- 1203-1208
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W1978923969
- Cited by
- 320
- References
- 21
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.